Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study.

Saved in:
Bibliographic Details
Title: Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study.
Authors: Suzuki R; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan., Ohkuma R; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan.; Comprehensive Cancer Information Center, Showa Medical University, Tokyo 142-8555, Japan., Watanabe M; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan., Mura E; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Tsurui T; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Iriguchi N; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Ishiguro T; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Hirasawa Y; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Ikeda G; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Shimokawa M; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Ariizumi H; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Kubota Y; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Yoshimura K; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan.; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan., Tsunoda T; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan.; Comprehensive Cancer Information Center, Showa Medical University, Tokyo 142-8555, Japan., Horiike A; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan., Tsuji M; Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan., Kiuchi Y; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan., Oguchi T; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan., Wada S; Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan.; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan.
Source: Biomedicines [Biomedicines] 2025 Dec 10; Vol. 13 (12). Date of Electronic Publication: 2025 Dec 10.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2227-9059
DOI:10.3390/biomedicines13123029